In early June 2026, GE HealthCare received FDA 510(k) clearance for its AI-enabled MIM Contour ProtégéAI+ 2.0 auto-contouring software, while also showcasing an expanded portfolio of AI-driven imaging ...
Japan leads in advanced radiotherapy technology; we are honored to bring our AI solution to this pioneering nation. 20-40% of cancer patients develop a secondary ...
Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.
GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI-enabled auto-contouring ...
GE HealthCare, a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions, announced it has received 510 (k) ...
In early June 2026, GE HealthCare received FDA 510(k) clearance for its AI-enabled MIM Contour ProtégéAI+ 2.0 auto-contouring software, while also showcasing an expanded portfolio of AI-driven imaging ...
US FDA grants 510 (k) clearance to GE HealthCare’s MIM Contour ProtégéAI+ 2.0, an AI-enabled auto-contouring software to assist radiation oncology care teams with treatment planning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results